Aeglea BioTherapeutics: Q4 Earnings Insights

Aeglea BioTherapeutics AGLE reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Aeglea BioTherapeutics missed estimated earnings by 6.9%, reporting an EPS of $-0.31 versus an estimate of $-0.29.

Revenue was up $3.64 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 4.44% drop in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.